Hypermethylation of TUSC5 genes in breast cancer tissue

Experimental Oncology

Volumn 34, Issue 4, 2012, Pages 370-372

  Bubnov, V ^a   Moskalev, E ^b   Petrovskiy, Y ^a   Bauer, A ^b   Hoheisel, J ^b   Zaporozhan, V ^a  

^a ODESSA NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breast cancer; Differentially expressed genes; DNA methylation

Indexed keywords

AKR1C2 PROTEIN; BIOLOGICAL MARKER; BISULFITE; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CDF15 PROTEIN; CORO2A PROTEIN; DNA; DNAJC12 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HOOK1 PROTEIN; PROTEIN DERIVATIVE; TFF1 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TOP2A PROTEIN; TP53INK1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUSC5 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER THERAPY; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EARLY DIAGNOSIS; EPIGENETICS; EXON; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; RESTRICTION MAPPING;

ADENOCARCINOMA; BREAST NEOPLASMS; CARRIER PROTEINS; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEINS;

EID: 84872404282     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Andre F, Michiels S, Dessen P, et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009; 10: 381-90.
2. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293: 1068-70. (Pubitemid 32758075)
3. Gal-Yam EN, Saito Y, Egger G, Jones PA. Cancer epigenetics: modifications, screening, and therapy. Annu Rev Med 2008; 59: 267-80. (Pubitemid 351287937)
4. Veeck J, Ropero S, Setien F, et al. BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors. J Clin Oncol 2010; 28: 2512-9.
5. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucl Acids Res 1997; 12: 2532-4. (Pubitemid 27303718)
6. Weng W, Yang Q, Huang M, et al. c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma. Biochem Biophys Res Commun 2011; 405: 278-84.
7. Bonazzi VF, Irwin D, Hayward NK. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma. Genes Chromosomes Cancer. 2009; 48:10-21.